GH Research PLC
GH Research PLC (GHRS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ghrs · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for GH Research PLC (GHRS) measures how much investors pay for each dollar of the company's trailing earnings. GHRS's current PE ratio of N/A is calculated by dividing its stock price of $20.12 by its TTM earnings per share of -$0.91.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2019 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
GH Research PLCYou GHRS | $1.4B | N/A | — | -$0.91 |
 Arbutus Biopharma Corporation ABUS | $838M | N/A | — | -$0.17 |
 Kura Oncology, Inc. KURA | $760M | N/A | — | -$3.18 |
 LENZ Therapeutics, Inc. LENZ | $211M | N/A | — | -$2.85 |
 Nanobiotix S.A. NBTX | $1.8B | N/A | — | -$0.50 |
 ProKidney Corp. PROK | $575M | N/A | — | -$0.52 |
 Palvella Therapeutics, Inc. PVLA | $1.2B | N/A | — | -$3.71 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.79 | — | |
2024-12-31 FY2024 | — | $-0.75 | — | |
2023-12-31 FY2023 | — | $-0.68 | — | |
2022-12-31 FY2022 | — | $-0.43 | — | |
2021-12-31 FY2021 | — | $-0.18 | — | |
2020-12-31 FY2020 | — | $-0.01 | — | |
2019-12-31 FY2019 | — | $-0.01 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for GH Research PLC (GHRS) measures how much investors pay for each dollar of the company's trailing earnings. GHRS's current PE ratio of N/A is calculated by dividing its stock price of $20.12 by its TTM earnings per share of -$0.91.
Frequently asked questions
GHRS pe ratio · 6 questionsGHRS's current PE ratio is N/A as of 2026-06-08, based on a stock price of $20.12 and TTM EPS of -$0.91. Data sourced from Financial Modeling Prep via GHRS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · GH Research PLC SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08